Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing

International Orthopaedics

Volumn 35, Issue 5, 2011, Pages 777-782

  Colombini, Alessandra ^a   Lombardi, Giovanni ^a   Galliera, Emanuela ^b   Dogliotti, Giada ^b   Randelli, Pietro ^b   Meerssemann, Alexander ^a   Mineo, Giuseppe ^b   Cabitza, Paolo ^b   Corsi, Massimiliano Marco ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ADULT; ARTICLE; BONE REMODELING; CONTROLLED STUDY; FEMALE; FRACTURE HEALING; HUMAN; HUMERUS FRACTURE; MALE; OSTEOSYNTHESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURGICAL DRAINAGE; UPREGULATION;

ADULT; AGED; BONE REMODELING; FEMALE; FRACTURE HEALING; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SHOULDER FRACTURES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955606228     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-010-1088-3     Document Type: Article

References (19)

1. Court-Brown CM, Garg A, McQueen MM (2001) The epidemiology of proximal humeral fractures. Acta Orthop Scand 72:365-371 (Pubitemid 32844080)
2. Palvanen M, Kannus P, Parkkari J et al (2000) The injury mechanisms of osteoporotic upper extremity fractures among older adults: a controlled study of 287 consecutive patients and their 108 controls. Osteoporos Int 11:822-831 (Pubitemid 32049471)
3. Burkhead WZ, Schienberg RR, Box G (1992) Surgical anatomy of the axillary nerve. J Shoulder Elbow Surg 1:31-36
4. DeFranco MJ, Brems JJ, Williams GR Jr et al (2006) Evaluation and management of valgus impacted four-part proximal humerus fractures. Clin Orthop Relat Res 442:109-114 (Pubitemid 44384171)
5. Kong YY, Boyle WJ, Penninger JM (2000) Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol Today 21:495-502
6. Theoleyre S, Wittrant Y, Tat SK et al (2004) The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodelling. Cytokine Growth Factor Rev 15:457-475 (Pubitemid 39550455)
7. Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155-192 (Pubitemid 351519689)
8. Boyce BF, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146
9. Hofbauer LC, Schoppet M (2001) Serum measurement of osteoprotegerin- clinical relevance and potential applications. Eur J Endocrinol 145:681-683 (Pubitemid 33133672)
10. Rogers A, Eastell R (2005) Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323-6331 (Pubitemid 41606564)
11. Kon T, Cho TJ, Aizawa T et al (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-1014 (Pubitemid 32467144)
12. Gardner MJ, Griffith MH, Dines JS et al (2004) A minimally invasive approach for plate fixation of the proximal humerus. Bull Hosp Jt Dis 62:18-23 (Pubitemid 39381785)
13. Kudlacek S, Schneider B, Woloszczuk W et al (2003) Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone 32:681-686 (Pubitemid 37303940)
14. Marchelli D, Piodi LP, Corradini C et al (2009) Increased serum OPG in atrophic nonunion shaft fractures. J Orthop Traumatol 10:55-58
15. Lee JS, Ryu CH, Moon NH et al (2009) Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. Arch Orthop Trauma Surg 129:711-718
16. Tan KB, Harrop J, Reddy M et al (1997) Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene 204:35-46 (Pubitemid 28022168)
17. Yun TJ, Chaudhary PM, Shu GL et al (1998) OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 161:6113-6121 (Pubitemid 28535982)
18. Malyankar UM, Scatena M, Suchland KL et al (2000) Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 275:20959-20962 (Pubitemid 30481782)
19. Hofbauer LC, Heufelder AE (2000) The role of receptor activator of nuclear factor-kB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85:2355-2363 (Pubitemid 32269185)